AU2008346205B2 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations Download PDF

Info

Publication number
AU2008346205B2
AU2008346205B2 AU2008346205A AU2008346205A AU2008346205B2 AU 2008346205 B2 AU2008346205 B2 AU 2008346205B2 AU 2008346205 A AU2008346205 A AU 2008346205A AU 2008346205 A AU2008346205 A AU 2008346205A AU 2008346205 B2 AU2008346205 B2 AU 2008346205B2
Authority
AU
Australia
Prior art keywords
present
hpmc
release
amount
capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2008346205A
Other languages
English (en)
Other versions
AU2008346205A1 (en
Inventor
Adrian Brown
Lee J. Gorringe
Wayne M. Matthews
Stephen Mark Mcallister
Danielle Genevieve Rebecca Russell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Capsugel Belgium NV
Original Assignee
Capsugel Belgium NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Capsugel Belgium NV filed Critical Capsugel Belgium NV
Publication of AU2008346205A1 publication Critical patent/AU2008346205A1/en
Assigned to CAPSUGEL BELGIUM NV reassignment CAPSUGEL BELGIUM NV Request for Assignment Assignors: GLAXO GROUP LIMITED
Application granted granted Critical
Publication of AU2008346205B2 publication Critical patent/AU2008346205B2/en
Priority to AU2012227154A priority Critical patent/AU2012227154A1/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
AU2008346205A 2007-11-08 2008-11-07 Pharmaceutical formulations Ceased AU2008346205B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2012227154A AU2012227154A1 (en) 2007-11-08 2012-09-17 Pharmaceutical formulations

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98638307P 2007-11-08 2007-11-08
US60/986,383 2007-11-08
PCT/IB2008/003872 WO2009087483A2 (en) 2007-11-08 2008-11-07 Pharmaceutical formulations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2012227154A Division AU2012227154A1 (en) 2007-11-08 2012-09-17 Pharmaceutical formulations

Publications (2)

Publication Number Publication Date
AU2008346205A1 AU2008346205A1 (en) 2009-07-16
AU2008346205B2 true AU2008346205B2 (en) 2012-07-19

Family

ID=40721919

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008346205A Ceased AU2008346205B2 (en) 2007-11-08 2008-11-07 Pharmaceutical formulations

Country Status (12)

Country Link
US (2) US20110117190A1 (enExample)
EP (1) EP2219624A2 (enExample)
JP (1) JP2011503048A (enExample)
KR (1) KR20100096141A (enExample)
CN (1) CN101917978A (enExample)
AU (1) AU2008346205B2 (enExample)
BR (1) BRPI0820381A2 (enExample)
CA (1) CA2705285A1 (enExample)
EA (1) EA201070568A1 (enExample)
MX (1) MX2010005092A (enExample)
TW (1) TW200936186A (enExample)
WO (1) WO2009087483A2 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US7883721B2 (en) * 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
MY142179A (en) * 2002-07-25 2010-10-15 Glaxo Group Ltd Multicomponent pharmaceutical dosage form
TW200526274A (en) * 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
AR048033A1 (es) * 2004-03-12 2006-03-22 Smithkline Beecham Plc Composicion farmaceutica para moldear componentes que comprende copolimero de poli(met)acrilato, cubierta, conector o espaciador de capsula moldeado por inyeccion que tiene la composicion farmaceutica y forma de dosificacion farmaceutica de multicomponentes a partir de dicha composicion
CN101827571A (zh) * 2007-10-15 2010-09-08 葛兰素集团有限公司 用于释放一种或多种药物成分的多部分剂型的连接件及所得剂型
EP2219583B1 (en) * 2007-10-15 2012-11-21 Capsugel Belgium NV Method and apparatus for manufacturing filled linkers
EP2209455A1 (en) * 2007-10-15 2010-07-28 Glaxo Group Limited Paneled capsule shells for release of pharmaceutical compositions
EP2219624A2 (en) * 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations
EP2320876A2 (en) * 2008-06-13 2011-05-18 Pfizer Inc. Hydroxypropyl cellulose capsule shell
DE102008031426B4 (de) * 2008-07-04 2014-07-31 Schott Ag Verfahren zur Herstellung einer Versiegelungsschicht für Dekorschichten, Glas- oder Glaskeramik-Artikel und dessen Verwendung
DE102008031428A1 (de) * 2008-07-04 2010-01-07 Schott Ag Dekorative Beschichtung von Glas- oder Glaskeramik-Artikeln
GB201010083D0 (en) * 2010-06-16 2010-07-21 Univ Bradford Compositions and methods
US20120251588A1 (en) * 2011-03-30 2012-10-04 Miyuki Fukasawa Coating Composition, Solid Preparation Coated Therewith, and Method for Preparing Solid Preparation
WO2013055668A1 (en) * 2011-10-12 2013-04-18 Dow Global Technologies Llc Injection-molded dosage form
EP2790729A4 (en) 2011-12-12 2015-08-12 Orbis Biosciences Inc PARTICULATE FORMULATIONS WITH DELAYED RELEASE
ITTO20120596A1 (it) * 2012-07-06 2014-01-07 Consiglio Nazionale Ricerche Procedimento e sistema per assemblare una forma di dosaggio orale, e forma di dosaggio orale
CA2913971C (en) * 2013-05-31 2022-08-02 Universal Stabilization Technologies, Inc. Polymeric compositions containing ambient-temperature stable biopharmaceuticals & methods for formulation thereof
CN106163564B (zh) * 2014-04-08 2018-10-09 陶氏环球技术有限责任公司 包含酯化纤维素醚的分散体
CN106535878B (zh) 2014-06-02 2022-11-01 科莱西奥生物科技有限公司 可张开的胃内滞留剂型
TWI535784B (zh) 2014-08-26 2016-06-01 財團法人工業技術研究院 剪切增稠配方、及包含其之複合材料
EP3981392A1 (en) * 2016-05-05 2022-04-13 Triastek, Inc. Controlled release dosage form
IL266377B2 (en) 2016-12-02 2023-10-01 Clexio Biosciences Ltd Gastric residence system
US20180282527A1 (en) 2017-03-30 2018-10-04 Shin-Etsu Chemical Co., Ltd. Injection molding composition containing hypromellose acetate succinate and method for producing same
US12214084B2 (en) 2017-07-11 2025-02-04 Qualicaps Co., Ltd. Enteric hard capsule
WO2019111132A1 (en) 2017-12-04 2019-06-13 Clexio Biosciences Ltd. Long acting gastric residence system
US12280153B2 (en) 2018-06-22 2025-04-22 Qualicaps Co., Ltd. Enteric hard capsule

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033569A1 (de) * 1996-03-13 1997-09-18 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Arzneimittelzubereitung für ace-hemmer
WO2005070401A1 (en) * 2004-01-16 2005-08-04 Glaxo Group Limited Encapsulation of lipid-based formulations in enteric polymers
WO2006107593A2 (en) * 2005-04-06 2006-10-12 Mallinckrodt Inc. Matrix-based pulse release pharmaceutical formulation

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3186910A (en) 1962-03-08 1965-06-01 Jacob A Glassman Method for producing peroral capsules
US3228789A (en) 1962-10-22 1966-01-11 Jacob A Glassman Peroral capsules and tablets and the method for making same
FR1454013A (fr) 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
NL7610038A (en) 1976-09-09 1978-03-13 Tapanahony N V Multichambered capsule for therapeutically active substances - has chambers of different solubility with contents differing quantitatively and qualitatively
WO1983001454A1 (en) 1981-10-21 1983-04-28 Smith, Charles, E. A method and composition for substrate coating
US4655840A (en) 1982-03-26 1987-04-07 Warner-Lambert Company Hydrophilic polymer compositions for injection molding
EG16028A (en) 1982-03-26 1986-12-30 Warner Lambert Co Apparatus and method for molding capsules
GR78492B (enExample) 1982-03-26 1984-09-27 Warner Lambert Co
US4790881A (en) 1982-03-26 1988-12-13 Warner-Lambert Company Molded hydrophilic polymer
FR2524311A1 (fr) 1982-04-05 1983-10-07 Azalbert Gilles Gelule compartimentee aux fins d'ingestions simultanees a effets differes
US4576284A (en) 1983-12-02 1986-03-18 Warner-Lambert Company Closing of filled capsules
CH661878A5 (de) 1983-11-04 1987-08-31 Warner Lambert Co Kapsel-dosierungsformen.
US4738724A (en) 1983-11-04 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from starch compositions
US4738817A (en) 1983-11-17 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from hydrophilic polymers
US5082655A (en) 1984-07-23 1992-01-21 Zetachron, Inc. Pharmaceutical composition for drugs subject to supercooling
US4629621A (en) 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
US4678516A (en) 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
US4764378A (en) 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
DE3612212A1 (de) 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
DE3727894A1 (de) 1987-08-21 1989-03-02 Stephan Dieter Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge
US5139790A (en) 1988-10-14 1992-08-18 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US5004601A (en) 1988-10-14 1991-04-02 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US5244668A (en) 1988-10-14 1993-09-14 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US5135752A (en) 1988-10-14 1992-08-04 Zetachron, Inc. Buccal dosage form
WO1990012567A1 (fr) 1989-04-21 1990-11-01 Moskovsky Avtomobilestroitelny Institut (Vtuz-Zil) Dispositif pour le dosage module de substances actives dans un milieu fonctionnel
DE4138513A1 (de) 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
WO1996010996A1 (en) 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
US5443461A (en) 1993-08-31 1995-08-22 Alza Corporation Segmented device for simultaneous delivery of multiple beneficial agents
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
DE4413350A1 (de) 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
DE19509807A1 (de) 1995-03-21 1996-09-26 Basf Ag Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
DE9414065U1 (de) 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
DE4431832A1 (de) * 1994-09-07 1996-03-14 Cordes Guenter Dr Arzneimittelzubereitung für ACE-Hemmer
DE19504831A1 (de) 1995-02-14 1996-09-05 Basf Ag Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose
DE19504832A1 (de) 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
DE19509805A1 (de) 1995-03-21 1996-09-26 Basf Ag Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica
DE19531277A1 (de) 1995-08-25 1997-02-27 Basf Ag Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren
JPH09165494A (ja) 1995-11-16 1997-06-24 Yuka Shell Epoxy Kk 硬化性エポキシ樹脂組成物およびその使用
DE19733505A1 (de) 1997-08-01 1999-02-04 Knoll Ag Schnell wirksames Analgeticum
DE19753297A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19753299A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19753298A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19753300A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19800927A1 (de) 1998-01-13 1999-07-15 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19812688A1 (de) 1998-03-23 1999-09-30 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
CA2391707C (en) * 1999-07-30 2010-05-11 Smithkline Beecham Plc Multi-component pharmaceutical dosage form
AU2001241192A1 (en) * 2000-03-23 2001-10-03 Shionogi And Co., Ltd. Enteric granular preparations of hardly water soluble drugs characterized by containing water-repellent component
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
DE60206889T2 (de) * 2001-02-27 2006-07-27 Astrazeneca Ab Pharmazeutische formulierung enthaltend bicalutamid
MY142179A (en) * 2002-07-25 2010-10-15 Glaxo Group Ltd Multicomponent pharmaceutical dosage form
EP1537880A4 (en) * 2002-09-11 2009-07-01 Takeda Pharmaceutical Sustained release preparation
TW200526274A (en) * 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
US20050129765A1 (en) * 2003-11-14 2005-06-16 Shaoling Li Controlled release of topiramate in liquid dosage forms
AR048033A1 (es) 2004-03-12 2006-03-22 Smithkline Beecham Plc Composicion farmaceutica para moldear componentes que comprende copolimero de poli(met)acrilato, cubierta, conector o espaciador de capsula moldeado por inyeccion que tiene la composicion farmaceutica y forma de dosificacion farmaceutica de multicomponentes a partir de dicha composicion
EP2209455A1 (en) * 2007-10-15 2010-07-28 Glaxo Group Limited Paneled capsule shells for release of pharmaceutical compositions
CN101827571A (zh) * 2007-10-15 2010-09-08 葛兰素集团有限公司 用于释放一种或多种药物成分的多部分剂型的连接件及所得剂型
EP2219624A2 (en) * 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033569A1 (de) * 1996-03-13 1997-09-18 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Arzneimittelzubereitung für ace-hemmer
WO2005070401A1 (en) * 2004-01-16 2005-08-04 Glaxo Group Limited Encapsulation of lipid-based formulations in enteric polymers
WO2006107593A2 (en) * 2005-04-06 2006-10-12 Mallinckrodt Inc. Matrix-based pulse release pharmaceutical formulation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
European Journal of Pharmaceutical Sciences (2005) 24 pp 207-212 *
International Journal of Pharmaceutics (2001) 217 pp 33-43 *

Also Published As

Publication number Publication date
CA2705285A1 (en) 2009-07-16
MX2010005092A (es) 2010-05-27
US20090148518A1 (en) 2009-06-11
JP2011503048A (ja) 2011-01-27
EP2219624A2 (en) 2010-08-25
WO2009087483A3 (en) 2009-10-22
BRPI0820381A2 (pt) 2015-05-19
TW200936186A (en) 2009-09-01
CN101917978A (zh) 2010-12-15
US20110117190A1 (en) 2011-05-19
AU2008346205A1 (en) 2009-07-16
EA201070568A1 (ru) 2010-12-30
KR20100096141A (ko) 2010-09-01
WO2009087483A2 (en) 2009-07-16

Similar Documents

Publication Publication Date Title
AU2008346205B2 (en) Pharmaceutical formulations
US8147871B2 (en) Pharmaceutical formulations
US20100074947A1 (en) Pharmaceutical Formulations
US8673350B2 (en) Pharmaceutical formulations
US20050175687A1 (en) Pharmaceutical formulations
AU2012227154A1 (en) Pharmaceutical formulations
HK1151737A (en) Pharmaceutical formulations
MXPA06010335A (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: CAPSUGEL BELGIUM NV

Free format text: FORMER APPLICANT(S): GLAXO GROUP LIMITED

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired